Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

EPLIN is a negative regulator of prostate cancer growth and invasion.

Sanders AJ, Martin TA, Ye L, Mason MD, Jiang WG.

J Urol. 2011 Jul;186(1):295-301. doi: 10.1016/j.juro.2011.03.038. Epub 2011 May 20.

PMID:
21600601
2.

EPLIN, epithelial protein lost in neoplasm.

Maul RS, Chang DD.

Oncogene. 1999 Dec 16;18(54):7838-41.

3.

Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation.

Sanders AJ, Parr C, Martin TA, Lane J, Mason MD, Jiang WG.

J Cell Physiol. 2008 Sep;216(3):780-9. doi: 10.1002/jcp.21460.

PMID:
18449907
4.

Androgen induction of prostate cancer cell invasion is mediated by ezrin.

Chuan YC, Pang ST, Cedazo-Minguez A, Norstedt G, Pousette A, Flores-Morales A.

J Biol Chem. 2006 Oct 6;281(40):29938-48. Epub 2006 Jul 26.

6.

Bone morphogenetic protein-9 induces apoptosis in prostate cancer cells, the role of prostate apoptosis response-4.

Ye L, Kynaston H, Jiang WG.

Mol Cancer Res. 2008 Oct;6(10):1594-606. doi: 10.1158/1541-7786.MCR-08-0171.

7.

Secreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancer.

Horvath LG, Lelliott JE, Kench JG, Lee CS, Williams ED, Saunders DN, Grygiel JJ, Sutherland RL, Henshall SM.

Prostate. 2007 Jul 1;67(10):1081-90.

PMID:
17476687
8.

Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cell lines and tissues with malignant progression.

Wu GJ, Wu MW, Wang SW, Liu Z, Qu P, Peng Q, Yang H, Varma VA, Sun QC, Petros JA, Lim SD, Amin MB.

Gene. 2001 Nov 14;279(1):17-31.

PMID:
11722842
9.

The HGF/SF-induced phosphorylation of paxillin, matrix adhesion, and invasion of prostate cancer cells were suppressed by NK4, an HGF/SF variant.

Parr C, Davies G, Nakamura T, Matsumoto K, Mason MD, Jiang WG.

Biochem Biophys Res Commun. 2001 Aug 3;285(5):1330-7.

PMID:
11478803
10.
11.

Down-regulation of prostasin serine protease: a potential invasion suppressor in prostate cancer.

Chen LM, Hodge GB, Guarda LA, Welch JL, Greenberg NM, Chai KX.

Prostate. 2001 Jul 1;48(2):93-103.

PMID:
11433419
12.

Quercetin inhibits invasion, migration and signalling molecules involved in cell survival and proliferation of prostate cancer cell line (PC-3).

Senthilkumar K, Arunkumar R, Elumalai P, Sharmila G, Gunadharini DN, Banudevi S, Krishnamoorthy G, Benson CS, Arunakaran J.

Cell Biochem Funct. 2011 Mar;29(2):87-95. doi: 10.1002/cbf.1725. Epub 2011 Feb 9.

PMID:
21308698
13.

Suppression of growth and invasive behavior of human prostate cancer cells by ProstaCaid™: mechanism of activity.

Jiang J, Eliaz I, Sliva D.

Int J Oncol. 2011 Jun;38(6):1675-82. doi: 10.3892/ijo.2011.996. Epub 2011 Apr 4.

PMID:
21468543
14.

The influence of CD44v3-v10 on adhesion, invasion and MMP-14 expression in prostate cancer cells.

Harrison GM, Davies G, Martin TA, Mason MD, Jiang WG.

Oncol Rep. 2006 Jan;15(1):199-206.

PMID:
16328056
15.

Chromosome 5 suppresses tumorigenicity of PC3 prostate cancer cells: correlation with re-expression of alpha-catenin and restoration of E-cadherin function.

Ewing CM, Ru N, Morton RA, Robinson JC, Wheelock MJ, Johnson KR, Barrett JC, Isaacs WB.

Cancer Res. 1995 Nov 1;55(21):4813-7.

16.

SKI-606 (Bosutinib) blocks prostate cancer invasion, growth, and metastasis in vitro and in vivo through regulation of genes involved in cancer growth and skeletal metastasis.

Rabbani SA, Valentino ML, Arakelian A, Ali S, Boschelli F.

Mol Cancer Ther. 2010 May;9(5):1147-57. doi: 10.1158/1535-7163.MCT-09-0962. Epub 2010 Apr 27.

17.

Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer.

Inoue K, Slaton JW, Eve BY, Kim SJ, Perrotte P, Balbay MD, Yano S, Bar-Eli M, Radinsky R, Pettaway CA, Dinney CP.

Clin Cancer Res. 2000 May;6(5):2104-19.

18.

Vitamin D3 modulated gene expression patterns in human primary normal and cancer prostate cells.

Guzey M, Luo J, Getzenberg RH.

J Cell Biochem. 2004 Oct 1;93(2):271-85.

PMID:
15368355
19.

Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis.

Fu Z, Smith PC, Zhang L, Rubin MA, Dunn RL, Yao Z, Keller ET.

J Natl Cancer Inst. 2003 Jun 18;95(12):878-89.

PMID:
12813171
20.

Multiple cellular mechanisms related to cyclin A1 in prostate cancer invasion and metastasis.

Wegiel B, Bjartell A, Tuomela J, Dizeyi N, Tinzl M, Helczynski L, Nilsson E, Otterbein LE, Härkönen P, Persson JL.

J Natl Cancer Inst. 2008 Jul 16;100(14):1022-36. doi: 10.1093/jnci/djn214. Epub 2008 Jul 8.

Supplemental Content

Support Center